Upcoming events – Phase III data for Chiasma and Novartis

Upcoming events – Phase III data for Chiasma and Novartis

Source: 
EP Vantage
snippet: 

Chiasma hopes to be able to file its oral acromegaly therapy by year-end, and Novartis wants to shore up its MS franchise.